Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey-Reference-Cited by-同舟云学术

Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Published:2017-07-12 Issue:1 Volume:18 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Schlessinger Daniel I.,Iyengar Sanjana,Yanes Arianna F.,Chiren Sarah G.,Godinez-Puig Victoria,Chen Brian R.,Kurta Anastasia O.,Schmitt Jochen,Deckert Stefanie,Furlan Karina C.,Poon Emily,Cartee Todd V.,Maher Ian A.,Alam Murad,Sobanko Joseph F.

Funder

Merz North America

IMPROVED (Measurement of Priority Outcome Variables in Dermatologic Surgery) Group

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-017-2069-2.pdf

Reference20 articles.

1. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713–20.

2. Mourouzis C, Boynton A, Grant J, Umar T, Wilson A, Macpheson D, et al. Cutaneous head and neck SCCs and risk of nodal metastasis – UK experience. J Craniomaxillofac Surg. 2009;37(8):443–7.